CD4 and COVID-19: Infection of SARS-CoV-2 can promote the activation of B cells during the acute phase, then mature B cells will present the viral antigen to CD4+ T cells and consequently induce rapid antibody clonal expansion and diversification in patients with COVID-19 (Zhang et al., 2022).